743 related articles for article (PubMed ID: 27387344)
21. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
24. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells.
Bezdenezhnykh N; Semesiuk N; Lykhova O; Zhylchuk V; Kudryavets Y
Exp Oncol; 2014 Jun; 36(2):72-8. PubMed ID: 24980759
[TBL] [Abstract][Full Text] [Related]
25. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis.
Pal M; Bhattacharya S; Kalyan G; Hazra S
Exp Cell Res; 2018 Jul; 368(2):137-146. PubMed ID: 29674112
[TBL] [Abstract][Full Text] [Related]
26. Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.
Ding J; Jin W; Chen C; Shao Z; Wu J
PLoS One; 2012; 7(7):e41942. PubMed ID: 22848668
[TBL] [Abstract][Full Text] [Related]
27. FOXA1 Induces E-Cadherin Expression at the Protein Level via Suppression of Slug in Epithelial Breast Cancer Cells.
Anzai E; Hirata K; Shibazaki M; Yamada C; Morii M; Honda T; Yamaguchi N; Yamaguchi N
Biol Pharm Bull; 2017; 40(9):1483-1489. PubMed ID: 28867731
[TBL] [Abstract][Full Text] [Related]
28. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
29. NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells.
Zhang Q; Mao Z; Sun J
Gene; 2019 Aug; 710():91-97. PubMed ID: 31002892
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
Chen Z; Wu J; Wang L; Zhao H; He J
Med Oncol; 2022 May; 39(5):83. PubMed ID: 35570226
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
33. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
[TBL] [Abstract][Full Text] [Related]
34. Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.
Bocca C; Ievolella M; Autelli R; Motta M; Mosso L; Torchio B; Bozzo F; Cannito S; Paternostro C; Colombatto S; Parola M; Miglietta A
Expert Opin Ther Targets; 2014 Feb; 18(2):121-35. PubMed ID: 24325753
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
36. Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness.
Angelucci C; Maulucci G; Lama G; Proietti G; Colabianchi A; Papi M; Maiorana A; De Spirito M; Micera A; Balzamino OB; Di Leone A; Masetti R; Sica G
PLoS One; 2012; 7(12):e50804. PubMed ID: 23251387
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction.
Feng R; Morine Y; Ikemoto T; Imura S; Iwahashi S; Saito Y; Shimada M
Cell Commun Signal; 2018 Sep; 16(1):54. PubMed ID: 30180849
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.
Comito G; Giannoni E; Segura CP; Barcellos-de-Souza P; Raspollini MR; Baroni G; Lanciotti M; Serni S; Chiarugi P
Oncogene; 2014 May; 33(19):2423-31. PubMed ID: 23728338
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
40. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
